Auctus Management bolts on drug company to PharmaZell
Swiss pharmaceuticals company Novartis has sold GEA Pharmaceuticals to Auctus Management, as the first step in its buy and build strategy for drug producer PharmaZell.
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .Issues with signing in? Click here
Don't have an account? Register now
Swiss pharmaceuticals company Novartis has sold GEA Pharmaceuticals to Auctus Management, as the first step in its buy and build strategy for drug producer PharmaZell.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
Copyright PEI Media
Not for publication, email or dissemination